Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005403
Status:
COMPLETED
Last Update Posted:
2016-02-18
First Post:
2000-05-25
Brief Title:
Heart Disease and the Black Health Disadvantage
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Heart Lung and Blood Institute NHLBI
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2000-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To utilize national population data sets prepared by the National Center for Health Statistics to 1 examine the current Black disadvantage in cardiovascular CV health 2 explore potential clinical and epidemiologic causes 3 incorporate emerging knowledge of new risk factors and 4 compare trends in medical treatment and risk factors for the four sex-race groups
Detailed Description:
BACKGROUND
The Black health disadvantage remains a pressing public health issue in the United States According to the Department of Health and Human Services Black and Minority Health Report 65000 excess deaths occur each year among Blacks when compared to the mortality experience of whites Cardiovascular diseases make by far the largest contribution to this loss of life accounting for over 30 percent of the excess Despite improvements in CV mortality for all four major sex-race groups during the 1970s the trends in heart disease in the United States began to diverge A 50 percent slowing of the decline in coronary mortality occurred among Blacks from 1978-1986 compared to whites and the gap in life expectancy between the races has widened As noted in the Report despite the widespread recognition of the importance of the problem our knowledge regarding the causes of these differentials in CV disease was inadequate To address this problem the Report recommended support for innovative uses of current data and cross-comparisons from different data sets emphasizing the unique contribution population-based studies can make to understanding the health status and needs of minority populations Given the deterioration of the Black health status relative to the majority population these recommendations took on new urgency
DESIGN NARRATIVE
Several separate analyses were conducted of prevalence surveys epidemiologic followup studies hospitalization surveys and vital statistics These separate analyses were subsequently combined into a comprehensive description of the clinical and epidemiologic determinants of the Black CV disadvantage and its future trends
The study completion date listed in this record was obtained from the End Date entered in the Protocol Registration and Results System PRS record
The Black health disadvantage remains a pressing public health issue in the United States According to the Department of Health and Human Services Black and Minority Health Report 65000 excess deaths occur each year among Blacks when compared to the mortality experience of whites Cardiovascular diseases make by far the largest contribution to this loss of life accounting for over 30 percent of the excess Despite improvements in CV mortality for all four major sex-race groups during the 1970s the trends in heart disease in the United States began to diverge A 50 percent slowing of the decline in coronary mortality occurred among Blacks from 1978-1986 compared to whites and the gap in life expectancy between the races has widened As noted in the Report despite the widespread recognition of the importance of the problem our knowledge regarding the causes of these differentials in CV disease was inadequate To address this problem the Report recommended support for innovative uses of current data and cross-comparisons from different data sets emphasizing the unique contribution population-based studies can make to understanding the health status and needs of minority populations Given the deterioration of the Black health status relative to the majority population these recommendations took on new urgency
DESIGN NARRATIVE
Several separate analyses were conducted of prevalence surveys epidemiologic followup studies hospitalization surveys and vital statistics These separate analyses were subsequently combined into a comprehensive description of the clinical and epidemiologic determinants of the Black CV disadvantage and its future trends
The study completion date listed in this record was obtained from the End Date entered in the Protocol Registration and Results System PRS record
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R03HL046120 | NIH | None | httpsreporternihgovquickSearchR03HL046120 |